Sign up
Quantellect · Congress · Trade Detail
NYSE: TEVATeva Pharma Industries Ltd ADR
RepublicanHouse

K. Michael Conaway sold Teva Pharma Industries Ltd ADR (NYSE: TEVA)

K. Michael Conaway (R-TX), a U.S. Representative, has disclosed 6 trades in Teva Pharma Industries Ltd ADR (TEVA) since 2014, 1 purchase and 5 sales, worth an estimated $48K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: K. Michael Conaway sold $1,001 - $15,000 of Teva Pharma Industries Ltd ADR (NYSE: TEVA) on May 4, 2016. Since that trade, TEVA is down -31.85% against the S&P 500 up +318.82%, an outperformance of -350.67%.

Across these filings, K. Michael Conaway has been a net seller of TEVA (a buy-to-sell ratio of 0.20). The most recent disclosed TEVA transaction shown was dated September 12, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

TEVA trades
6
Disclosed Vol
$48K
Buys
1
17%
Sells
5
83%
Buy / Sell
0.20
ratio
First → Last
2014–2016

K. Michael Conaway's TEVA trades vs the price

TEVA is down -31.85% since K. Michael Conaway sold on May 4, 2016, versus +318.82% for the S&P 500.

Performance since this trade

Price change since trade
-31.85%
S&P 500 change since trade
+318.82%
Outperformance vs S&P 500
-350.67%

All K. Michael Conaway TEVA trades

TradedTypeSizeReturnEst. profit
September 12, 2016SELL$49.42-29.77%
May 11, 2016SELL$48.18-27.95%
May 4, 2016SELL$50.93-31.85%
February 9, 2015SELL$51.83-33.03%
March 12, 2014SELL$43.99-21.09%
March 6, 2014BUY$44.95-22.77%-$2K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

K. Michael Conaway & TEVA trading FAQ

Is it legal for K. Michael Conaway to trade Teva Pharma Industries Ltd ADR (TEVA) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Teva Pharma Industries Ltd ADR (TEVA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did K. Michael Conaway sell TEVA?

K. Michael Conaway disclosed a sale of $1,001 - $15,000 of Teva Pharma Industries Ltd ADR (TEVA) on May 4, 2016, according to public STOCK Act filings.

How has TEVA performed since K. Michael Conaway's trade?

Since K. Michael Conaway sold TEVA on May 4, 2016, the stock is down -31.85%, versus +318.82% for the S&P 500 over the same period, an outperformance of -350.67%.

How many times has K. Michael Conaway traded TEVA?

K. Michael Conaway has disclosed 6 TEVA trades since 2014 (1 purchase and 5 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional TEVA trades?

Quantellect tracks every disclosed congressional trade in Teva Pharma Industries Ltd ADR (TEVA) on the Teva Pharma Industries Ltd ADR congressional trading page, which aggregates filings across all members of Congress.

K. Michael Conaway's TEVA tradesAll congressional filings for Teva Pharma Industries Ltd ADRK. Michael Conaway's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.